Posted by Michael Wonder on 15 Oct 2019
Pharmaceutical Benefits Advisory Committee responds to criticism
15 October 2019 - Chair Andrew Wilson told newsGP suggestions of delayed approvals are nothing new and Australia has one of ‘the fastest systems in the world’.
Medicines Australia Chief Executive Elizabeth de Somer told Fairfax that an overly bureaucratic approval process means Australia is lagging behind other OECD countries regarding time taken to subsidise new medicines.
The lobby group also commissioned a report which found drugs launched in Australia between 1986 and 2000 helped hospitals reduce costs by $3.47 billion, and that new cancer drugs helped save 3500 lives last year.
